scispace - formally typeset
T

Tal Galili

Researcher at Tel Aviv University

Publications -  28
Citations -  1936

Tal Galili is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Population & Cluster (physics). The author has an hindex of 12, co-authored 27 publications receiving 1313 citations.

Papers
More filters
Journal ArticleDOI

dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering

TL;DR: dendextend is an R package for creating and comparing visually appealing tree diagrams that provides utility functions for manipulating dendrogram objects as well as several advanced methods for comparing trees to one another (both statistically and visually).
Journal ArticleDOI

heatmaply: an R package for creating interactive cluster heatmaps for online publishing.

TL;DR: Heatmaply as discussed by the authors is an R package for easily creating interactive cluster heatmaps that can be shared online as a stand-alone HTML file, which includes a tooltip display of values when hovering over cells, as well as the ability to zoom in to specific sections of the figure from the data matrix, the side dendrograms, or annotated labels.
Journal ArticleDOI

The Proprioceptive System Masterminds Spinal Alignment: Insight into the Mechanism of Scoliosis

TL;DR: A central role for the proprioceptive system in maintaining spinal alignment is uncovered, suggesting that both receptor types may be required for this regulatory mechanism.
Journal ArticleDOI

Quantifying the buildup in extent and complexity of free exploration in mice

TL;DR: This study shows that mouse exploratory behavior consists of sequences of repeated motion: iterative processes that increase in extent and complexity, whose presumed function is a systematic active management of input acquired during the exploration of a novel environment.
Journal ArticleDOI

Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials

TL;DR: The proportion of smokers who use smoking cessation medications who benefit from doing so decreases during the course of the first year, but a net benefit still remains at 12 months.